RPRX Short Positions, Funds Shorting Royalty Pharma plc

Royalty Pharma plc
US ˙ NasdaqGS ˙ GB00BMVP7Y09

Funds Shorting Royalty Pharma plc

This page shows institutions, funds, and major shareholders that have reported short positions in their last reporting period. We consider put option positions to be short positions and include all institutions that have disclosed put options here. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Upgradeto unlock premium data.

File Date Source Investor Type Avg Price
(Est)
Shares Δ Shares
(%)
Reported
Value
($1000)
Δ Value
(%)
Port Alloc
(%)
2025-08-14 13F Caption Management, LLC Put 0 -100.00 0 -100.00
2025-08-14 13F Citadel Advisors Llc Put 69,400 4.20 2,500 20.60
2025-08-14 13F Millennium Management Llc Put 0 -100.00 0
2025-08-14 13F Point72 Asset Management, L.P. Put 129,100 0.00 4,651 15.75
2025-08-14 13F Bank Of America Corp /de/ Put 0 -100.00 0 -100.00
2025-08-12 13F Jpmorgan Chase & Co Put 40,000 1,441
2025-08-14 13F Susquehanna International Group, Llp Put 89,100 97.12 3,210 128.14
2025-08-14 13F UBS Group AG Put 32,800 0.00 1,182 15.67
2025-08-12 13F Proequities, Inc. Put 0 0
2025-08-14 13F Jane Street Group, Llc Put 63,300 859.09 2,281 1,012.20
2025-08-14 13F Group One Trading, L.p. Put 42,700 -68.39 1,538 -63.42
2025-07-28 13F Twin Tree Management, LP Put 0 -100.00 0 -100.00
2025-08-14 13F J. Goldman & Co LP Put 0 -100.00 0
2025-08-05 13F Simplex Trading, Llc Put 30,700 40.18 1
Other Listings
DE:RPD €30.68
MX:RPRX N
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista